Sintetica Elevates Drug Production with Rockwell Automation

Sintetica Elevates Drug Production with Rockwell Automation

Rockwell Automation (NYSE: ROK) drives manufacturing excellence. On June 26, Sintetica adopted Rockwell's PharmaSuite MES. This Swiss pharmaceutical company enhances its operations.

Swiss Facility Boosts Efficiency

Sintetica's Swiss plant benefits from this integration. It improves quality and insights. External interactions also strengthen. Faster batch reviews shorten market time. Innovative therapies will reach patients sooner. These include anesthesia and pain management drugs.

Positive Operator Feedback Emerges

Rockwell Automation consultants partnered closely with Sintetica. They supported design and implementation. A pilot ran on two lines. Operator feedback was very positive. Data-driven insights reduce monitoring time. They also streamline information dissemination.

Rockwell Automation's Global Reach

Rockwell Automation provides industrial automation solutions. They offer digital transformation. Their reach spans North America and Europe. The Middle East and Africa are also covered. Asia Pacific and Latin America benefit too.